The artificial organs and bionic implants market size has grown strongly in recent years. It will grow from $48.75 billion in 2025 to $52.76 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to limited availability of artificial organs, reliance on mechanical bionics, high cost of early bionic implants, low adoption due to lack of awareness, dependence on hospital-based implant procedures.
The artificial organs and bionic implants market size is expected to see strong growth in the next few years. It will grow to $71.53 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to advancements in electronic bionics and neural interfaces, increasing research in regenerative medicine, growing geriatric population and chronic disease prevalence, expansion of ambulatory surgical centers, rising government support and funding for medical device innovation. Major trends in the forecast period include rising adoption of advanced prosthetics and bionic limbs, increasing integration of neural implants and sensory devices, growing demand for artificial organs due to organ shortages, focus on personalized and patient-specific implants, enhanced post-surgical rehabilitation and support technologies.
The increasing prevalence of organ transplants is expected to propel the growth of the artificial organs and bionic implants market in the coming years. Organ transplants are surgical procedures in which a healthy organ from a donor is implanted into a recipient whose own organ is diseased, damaged, or non-functional. The rise in organ transplants is driven by increasing incidences of chronic diseases and organ failures, along with advancements in medical technology and surgical techniques. Artificial organs and bionic implants support organ transplantation by offering temporary solutions, reducing waiting periods, improving patient outcomes, and providing alternatives when donor organs are not available. For instance, in January 2025, according to the Organ Procurement and Transplantation Network, a US-based non-profit organization, organ transplants surpassed 48,000 in 2024, reflecting a 3.3% increase compared to transplants performed in 2023. Therefore, the increasing prevalence of organ transplants is driving the growth of the artificial organs and bionic implants market.
The rise in the elderly population is expected to drive the growth of the artificial organs and bionic implants market going forward. The elderly population includes individuals aged 60 or 65 and above who require specialized care and services due to age-related health and lifestyle challenges. The elderly population is increasing as a result of rising life expectancy supported by advancements in healthcare and improved living conditions. Artificial organs and bionic implants assist the elderly population by compensating for age-related organ deterioration and restoring critical physiological functions. For example, in January 2024, according to a report published by Population Reference Bureau, a US-based non-profit organization involved in collecting statistical data for research and academic purposes, the number of Americans aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050, representing a 47% rise. Consequently, this age group’s share of the total US population is expected to expand from 17% to 23% over this period. Therefore, the growing elderly population is contributing to the growth of the artificial organs and bionic implants market.
Major companies operating in the artificial organs and bionic implants market are focusing on the development of technologically advanced solutions, such as brain implant technology systems, to improve cognitive function and treat neurological disorders. Brain implant technology systems consist of devices that interact with the brain to monitor, stimulate, or alter neural activity for medical treatment, neuroprosthetics, or research applications. For instance, in May 2023, Neuralink Corp., a US-based neurotechnology company, received Food and Drug Administration (FDA) approval to begin its first human clinical trials for its brain implant technology, which is designed to help individuals with severe paralysis regain the ability to communicate with and control external devices using their thoughts. This approval represents a major milestone for the company, which previously faced challenges, including a rejection related to safety concerns. The trial will evaluate the device’s ability to interpret neural signals and transmit them via Bluetooth to control computers and mobile devices, potentially supporting patients with conditions such as amyotrophic lateral sclerosis (ALS).
Major companies operating in the artificial organs and bionic implants market are Medtronic plc, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Terumo Medical Corp., Edwards Lifesciences Corporation, Ottobock SE and Co. KGaA, Cochlear Limited, Ossur hf., Thoratec Corporation, Berlin Heart GmbH, Jarvik Heart Inc., SynCardia Systems LLC, BiVACOR Inc., Gambro AB, Pixium Vision, ALVI Labs, WillowWood Global LLC, Nano Retina Inc., Organovo Holdings Inc., Abbott Laboratories, ABIOMED Inc., Ekso Bionics Holdings Inc., ReWalk Robotics Ltd, LivaNova PLC, Second Sight Medical Products Inc.
North America was the largest region in the artificial organs and bionic implants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial organs and bionic implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial organs and bionic implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the artificial organs and bionic implants market by increasing costs for imported high-precision components, sensors, and prosthetic materials. Segments such as electronic bionics and advanced neural implants are particularly affected, with Asia-Pacific and European regions facing significant import duties. This has led to higher device prices and slowed adoption in cost-sensitive markets. However, tariffs have also encouraged local manufacturing, investment in domestic innovation, and development of cost-optimized solutions for global markets.
The artificial organs and bionic implants market research report is one of a series of new reports that provides artificial organs and bionic implants market statistics, including artificial organs and bionic implants industry global market size, regional shares, competitors with a artificial organs and bionic implants market share, detailed artificial organs and bionic implants market segments, market trends and opportunities, and any further data you may need to thrive in the artificial organs and bionic implants industry. This artificial organs and bionic implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Artificial organs and bionic implants are advanced medical technologies created to replace or enhance the function of damaged or missing organs and body parts. Their goal is to restore normal bodily functions or improve quality of life for people with severe injuries or organ failure.
The primary categories of products in the artificial organs and bionic implants market include artificial organs and artificial bionics. Artificial organs are engineered devices designed to replace natural organs in the human body while performing the same functions as the original organs. This segment includes technologies such as mechanical bionics and electronic bionics and serves a wide range of end users, including hospitals, ambulatory surgical centers, and other facilities.
The artificial organs and bionic implants market consists of sales of cochlear implants, neural implants, artificial bladders, and bionic arms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The artificial organs and bionic implants market size is expected to see strong growth in the next few years. It will grow to $71.53 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to advancements in electronic bionics and neural interfaces, increasing research in regenerative medicine, growing geriatric population and chronic disease prevalence, expansion of ambulatory surgical centers, rising government support and funding for medical device innovation. Major trends in the forecast period include rising adoption of advanced prosthetics and bionic limbs, increasing integration of neural implants and sensory devices, growing demand for artificial organs due to organ shortages, focus on personalized and patient-specific implants, enhanced post-surgical rehabilitation and support technologies.
The increasing prevalence of organ transplants is expected to propel the growth of the artificial organs and bionic implants market in the coming years. Organ transplants are surgical procedures in which a healthy organ from a donor is implanted into a recipient whose own organ is diseased, damaged, or non-functional. The rise in organ transplants is driven by increasing incidences of chronic diseases and organ failures, along with advancements in medical technology and surgical techniques. Artificial organs and bionic implants support organ transplantation by offering temporary solutions, reducing waiting periods, improving patient outcomes, and providing alternatives when donor organs are not available. For instance, in January 2025, according to the Organ Procurement and Transplantation Network, a US-based non-profit organization, organ transplants surpassed 48,000 in 2024, reflecting a 3.3% increase compared to transplants performed in 2023. Therefore, the increasing prevalence of organ transplants is driving the growth of the artificial organs and bionic implants market.
The rise in the elderly population is expected to drive the growth of the artificial organs and bionic implants market going forward. The elderly population includes individuals aged 60 or 65 and above who require specialized care and services due to age-related health and lifestyle challenges. The elderly population is increasing as a result of rising life expectancy supported by advancements in healthcare and improved living conditions. Artificial organs and bionic implants assist the elderly population by compensating for age-related organ deterioration and restoring critical physiological functions. For example, in January 2024, according to a report published by Population Reference Bureau, a US-based non-profit organization involved in collecting statistical data for research and academic purposes, the number of Americans aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050, representing a 47% rise. Consequently, this age group’s share of the total US population is expected to expand from 17% to 23% over this period. Therefore, the growing elderly population is contributing to the growth of the artificial organs and bionic implants market.
Major companies operating in the artificial organs and bionic implants market are focusing on the development of technologically advanced solutions, such as brain implant technology systems, to improve cognitive function and treat neurological disorders. Brain implant technology systems consist of devices that interact with the brain to monitor, stimulate, or alter neural activity for medical treatment, neuroprosthetics, or research applications. For instance, in May 2023, Neuralink Corp., a US-based neurotechnology company, received Food and Drug Administration (FDA) approval to begin its first human clinical trials for its brain implant technology, which is designed to help individuals with severe paralysis regain the ability to communicate with and control external devices using their thoughts. This approval represents a major milestone for the company, which previously faced challenges, including a rejection related to safety concerns. The trial will evaluate the device’s ability to interpret neural signals and transmit them via Bluetooth to control computers and mobile devices, potentially supporting patients with conditions such as amyotrophic lateral sclerosis (ALS).
Major companies operating in the artificial organs and bionic implants market are Medtronic plc, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Terumo Medical Corp., Edwards Lifesciences Corporation, Ottobock SE and Co. KGaA, Cochlear Limited, Ossur hf., Thoratec Corporation, Berlin Heart GmbH, Jarvik Heart Inc., SynCardia Systems LLC, BiVACOR Inc., Gambro AB, Pixium Vision, ALVI Labs, WillowWood Global LLC, Nano Retina Inc., Organovo Holdings Inc., Abbott Laboratories, ABIOMED Inc., Ekso Bionics Holdings Inc., ReWalk Robotics Ltd, LivaNova PLC, Second Sight Medical Products Inc.
North America was the largest region in the artificial organs and bionic implants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial organs and bionic implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial organs and bionic implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the artificial organs and bionic implants market by increasing costs for imported high-precision components, sensors, and prosthetic materials. Segments such as electronic bionics and advanced neural implants are particularly affected, with Asia-Pacific and European regions facing significant import duties. This has led to higher device prices and slowed adoption in cost-sensitive markets. However, tariffs have also encouraged local manufacturing, investment in domestic innovation, and development of cost-optimized solutions for global markets.
The artificial organs and bionic implants market research report is one of a series of new reports that provides artificial organs and bionic implants market statistics, including artificial organs and bionic implants industry global market size, regional shares, competitors with a artificial organs and bionic implants market share, detailed artificial organs and bionic implants market segments, market trends and opportunities, and any further data you may need to thrive in the artificial organs and bionic implants industry. This artificial organs and bionic implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Artificial organs and bionic implants are advanced medical technologies created to replace or enhance the function of damaged or missing organs and body parts. Their goal is to restore normal bodily functions or improve quality of life for people with severe injuries or organ failure.
The primary categories of products in the artificial organs and bionic implants market include artificial organs and artificial bionics. Artificial organs are engineered devices designed to replace natural organs in the human body while performing the same functions as the original organs. This segment includes technologies such as mechanical bionics and electronic bionics and serves a wide range of end users, including hospitals, ambulatory surgical centers, and other facilities.
The artificial organs and bionic implants market consists of sales of cochlear implants, neural implants, artificial bladders, and bionic arms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Artificial Organs and Bionic Implants Market Characteristics
3. Artificial Organs and Bionic Implants Market Supply Chain Analysis
4. Global Artificial Organs and Bionic Implants Market Trends and Strategies
5. Artificial Organs and Bionic Implants Market Analysis of End Use Industries
7. Global Artificial Organs and Bionic Implants Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Artificial Organs and Bionic Implants Total Addressable Market (TAM) Analysis for the Market
9. Artificial Organs and Bionic Implants Market Segmentation
10. Artificial Organs and Bionic Implants Market Regional and Country Analysis
11. Asia-Pacific Artificial Organs and Bionic Implants Market
12. China Artificial Organs and Bionic Implants Market
13. India Artificial Organs and Bionic Implants Market
14. Japan Artificial Organs and Bionic Implants Market
15. Australia Artificial Organs and Bionic Implants Market
16. Indonesia Artificial Organs and Bionic Implants Market
17. South Korea Artificial Organs and Bionic Implants Market
18. Taiwan Artificial Organs and Bionic Implants Market
19. South East Asia Artificial Organs and Bionic Implants Market
20. Western Europe Artificial Organs and Bionic Implants Market
21. UK Artificial Organs and Bionic Implants Market
22. Germany Artificial Organs and Bionic Implants Market
23. France Artificial Organs and Bionic Implants Market
24. Italy Artificial Organs and Bionic Implants Market
25. Spain Artificial Organs and Bionic Implants Market
26. Eastern Europe Artificial Organs and Bionic Implants Market
27. Russia Artificial Organs and Bionic Implants Market
28. North America Artificial Organs and Bionic Implants Market
29. USA Artificial Organs and Bionic Implants Market
30. Canada Artificial Organs and Bionic Implants Market
31. South America Artificial Organs and Bionic Implants Market
32. Brazil Artificial Organs and Bionic Implants Market
33. Middle East Artificial Organs and Bionic Implants Market
34. Africa Artificial Organs and Bionic Implants Market
36. Artificial Organs and Bionic Implants Market Competitive Landscape and Company Profiles
37. Artificial Organs and Bionic Implants Market Other Major and Innovative Companies
40. Artificial Organs and Bionic Implants Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Artificial Organs And Bionic Implants Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses artificial organs and bionic implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for artificial organs and bionic implants? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial organs and bionic implants market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Artificial Organs; Artificial Bionics2) By Technology: Mechanical Bionics; Electronic Bionics
3) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Artificial Organs: Artificial Heart; Artificial Kidney; Artificial Liver; Artificial Pancreas; Artificial Lungs2) By Artificial Bionics: Bionic Limbs; Bionic Eyes; Bionic Ears; Neural Implants; Bionic Skin
Companies Mentioned: Medtronic plc; Asahi Kasei Medical Co. Ltd.; B. Braun Melsungen AG; Terumo Medical Corp.; Edwards Lifesciences Corporation; Ottobock SE and Co. KGaA; Cochlear Limited; Ossur hf.; Thoratec Corporation; Berlin Heart GmbH; Jarvik Heart Inc.; SynCardia Systems LLC; BiVACOR Inc.; Gambro AB; Pixium Vision; ALVI Labs; WillowWood Global LLC; Nano Retina Inc.; Organovo Holdings Inc.; Abbott Laboratories; ABIOMED Inc.; Ekso Bionics Holdings Inc.; ReWalk Robotics Ltd; LivaNova PLC; Second Sight Medical Products Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Artificial Organs and Bionic Implants market report include:- Medtronic plc
- Asahi Kasei Medical Co. Ltd.
- B. Braun Melsungen AG
- Terumo Medical Corp.
- Edwards Lifesciences Corporation
- Ottobock SE and Co. KGaA
- Cochlear Limited
- Ossur hf.
- Thoratec Corporation
- Berlin Heart GmbH
- Jarvik Heart Inc.
- SynCardia Systems LLC
- BiVACOR Inc.
- Gambro AB
- Pixium Vision
- ALVI Labs
- WillowWood Global LLC
- Nano Retina Inc.
- Organovo Holdings Inc.
- Abbott Laboratories
- ABIOMED Inc.
- Ekso Bionics Holdings Inc.
- ReWalk Robotics Ltd
- LivaNova PLC
- Second Sight Medical Products Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 52.76 Billion |
| Forecasted Market Value ( USD | $ 71.53 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
